| Record Information |
| Version |
3.5 |
| Creation Date |
2006-08-15 16:06:05 -0600 |
| Update Date |
2013-02-08 11:19:14 -0700 |
| HMDB ID |
HMDB00586 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Potassium |
| Description |
Potassium is an essential electrolyte. Potassium balance is crucial for regulating the excitability of nerves and muscles and so critical for regulating contractility of cardiac muscle. Although the most important changes seen in the presence of deranged potassium are cardiac, smooth muscle is also affected with increasing muscle weakness, a feature of both hyperkalaemia and hypokalaemia. Physiologically, it exists as an ion in the body. Potassium (K+) is a positively charged electrolyte, cation, which is present throughout the body in both intracellular and extracellular fluids. The majority of body potassium, >90%, are intracellular. It moves freely from intracellular fluid (ICF) to extracellular fluid (ECF) and vice versa when adenosine triphosphate increases the permeability of the cell membrane. It is mainly replaced inside or outside the cells by another cation, sodium (Na+). The movement of potassium into or out of the cells is linked to certain body hormones and also to certain physiological states. Standard laboratory tests measure ECF potassium. Potassium enters the body rapidly during food ingestion. Insulin is produced when a meal is eaten; this causes the temporary movement of potassium from ECF to ICF. Over the ensuing hours, the kidneys excrete the ingested potassium and homeostasis is returned. In the critically ill patient, suffering from hyperkalaemia, this mechanism can be manipulated beneficially by administering high concentration (50%) intravenous glucose. Insulin can be added to the glucose, but glucose alone will stimulate insulin production and cause movement of potassium from ECF to ICF. The stimulation of alpha receptors causes increased movement of potassium from ICF to ECF. A noradrenaline infusion can elevate serum potassium levels. An adrenaline infusion, or elevated adrenaline levels, can lower serum potassium levels. Metabolic acidosis causes a rise in extracellular potassium levels. In this situation, excess of hydrogen ions (H+) are exchanged for intracellular potassium ions, probably as a result of the cellular response to a falling blood pH. Metabolic alkalosis causes the opposite effect, with potassium moving into the cells. (PMID: 17883675 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- K+
- Kalium
- Potassium
- Potassium (ion)
- Potassium (K+)
- Potassium cation
- Potassium ion
- Potassium ion (K+)
- Potassium ion (K1+)
- Potassium ion(+)
- Potassium ion(1+)
- Potassium monocation
- Potassium(+)
- Potassium(1+)
- Potassium(1+) ion
- Potassium(I) cation
|
| Chemical Formula |
K |
| Average Molecular Weight |
39.0983 |
| Monoisotopic Molecular Weight |
38.963706861 |
| IUPAC Name |
potassium |
| Traditional IUPAC Name |
potassium |
| CAS Registry Number |
7440-09-7 |
| SMILES |
[K+] |
| InChI Identifier |
InChI=1S/K/q+1 |
| InChI Key |
NPYPAHLBTDXSSS-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Inorganic Compounds |
| Super Class |
Homogeneous Metal Compounds |
| Class |
Homogeneous Alkali Metal Compounds |
| Sub Class |
N/A |
| Other Descriptors |
- a cation(Cyc)
- alkali metal cation(ChEBI)
- elemental potassium(ChEBI)
- monoatomic monocation(ChEBI)
- monovalent inorganic cation(ChEBI)
|
| Substituents |
|
| Direct Parent |
Homogeneous Alkali Metal Compounds |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
|
| Application |
Not Available |
| Cellular locations |
- Extracellular
- Golgi apparatus
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
63.2 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
- Extracellular
- Golgi apparatus
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
Not Available
|
| Pathways |
| Name |
SMPDB Link |
KEGG Link |
| Lactose Degradation |
SMP00457
|
Not Available
|
| Trehalose Degradation |
SMP00467
|
Not Available
|
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
4600.0 +/- 500.0 uM |
Children (1-13 year old) |
Both |
Normal |
Mean concentration of potassium in blood plasma...
|
| Blood |
Detected and Quantified |
|
4200.0 (3600.0-4800.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
4100.0 (3600.0-4600.0) uM |
Adult (>18 years old) |
Female |
Normal |
Mean concentration of potassium in blood serum...
|
| Blood |
Detected and Quantified |
|
4560.0 +/- 560.0 uM |
Newborn (0-30 days old) |
Not Specified |
Normal |
Mean concentration of potassium in blood plasma...
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
2960.0 (2620.0-3300.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
2163 +/- 274 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3593.14 (553.33-8078.58) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by ICP MS
|
| Urine |
Detected and Quantified |
|
4605.2 (2631.5 - 6578.9) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
4407.8 +/- 131.5 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
5460.00 +/- 197.00 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
4500.00 (3500.00-5500.00) uM |
Adult (>18 years old) |
Both |
Renal tubular acidosis, distal (RTA type I) |
Not Available |
| Blood |
Detected and Quantified |
|
2750.00 (2500.00-3000.00) uM |
Adult (>18 years old) |
Both |
Renal tubular acidosis |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Renal tubular acidosis, distal, RTA type 1 |
- http://www.metagene.de/program/d.prg?mp=RENAL%20TUBULAR%20ACIDOSIS,%20DISTAL,%20RTA%20TYPE%20I
|
|
| Associated OMIM IDs |
- 179800
(Renal tubular acidosis, distal, RTA type 1)
|
| External Links |
| DrugBank ID |
DB01345  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB003521 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
Not Available |
| KEGG Compound ID |
C00238  |
| BioCyc ID |
K%2b  |
| BiGG ID |
34349  |
| Wikipedia Link |
Potassium  |
| NuGOwiki Link |
HMDB00586  |
| Metagene Link |
HMDB00586  |
| METLIN ID |
3197  |
| PubChem Compound |
Not Available |
| PDB ID |
Not Available |
| ChEBI ID |
26216  |
| References |
| Synthesis Reference |
Alberti, Augusto. Recovering potassium salts from the refuse liquor of the manufacture of tartaric acid. (1910), US 957295 19100510 CAN 4:13164 AN 1910:13164 |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Schaafsma A, de Vries PJ, Saris WH: Delay of natural bone loss by higher intakes of specific minerals and vitamins. Crit Rev Food Sci Nutr. 2001 May;41(4):225-49.
Pubmed: 11401244
- Preuss HG: Diet, genetics and hypertension. J Am Coll Nutr. 1997 Aug;16(4):296-305.
Pubmed: 9263178
- Beede DK: Mineral and water nutrition. Vet Clin North Am Food Anim Pract. 1991 Jul;7(2):373-90.
Pubmed: 1893277
|
| Enzymes |
| Name: |
2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial
|
| Reactions: |
- 3-methyl-2-oxobutanoate + [dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] lipoyllysine = [dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine + CO2 [RN:R01701]
|
| Gene Name: |
BCKDHA |
| Uniprot ID: |
P12694  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Pyridoxal kinase
|
| Reactions: |
- ATP + pyridoxal = ADP + pyridoxal 5'-phosphate [RN:R00174]
|
| Gene Name: |
PDXK |
| Uniprot ID: |
O00764  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Tubulin--tyrosine ligase
|
| Reactions: |
- ATP + detyrosinated alpha-tubulin + L-tyrosine = alpha-tubulin + ADP + phosphate [RN:R04730]
|
| Gene Name: |
TTL |
| Uniprot ID: |
Q8NG68  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Pyruvate kinase
|
| Reactions: |
- ATP + pyruvate = ADP + phosphoenolpyruvate [RN:R00200]
|
| Gene Name: |
Not Available |
| Uniprot ID: |
Q16715  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Pyruvate kinase
|
| Reactions: |
- ATP + pyruvate = ADP + phosphoenolpyruvate [RN:R00200]
|
| Gene Name: |
Not Available |
| Uniprot ID: |
Q16716  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Pyruvate kinase
|
| Reactions: |
- ATP + pyruvate = ADP + phosphoenolpyruvate [RN:R00200]
|
| Gene Name: |
PKM2 |
| Uniprot ID: |
Q504U3  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Pyruvate kinase
|
| Reactions: |
- ATP + pyruvate = ADP + phosphoenolpyruvate [RN:R00200]
|
| Gene Name: |
PKM2 |
| Uniprot ID: |
Q8WUW7  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|